1. Home
  2. PASW vs JSPR Comparison

PASW vs JSPR Comparison

Compare PASW & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASW

Ping An Biomedical Co. Ltd. Ordinary Shares

N/A

Current Price

$0.15

Market Cap

20.4M

ML Signal

N/A

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.82

Market Cap

23.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASW
JSPR
Founded
2021
2018
Country
Hong Kong
United States
Employees
7
22
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
23.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PASW
JSPR
Price
$0.15
$0.82
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$15.50
AVG Volume (30 Days)
140.8K
265.3K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.62
52 Week High
$1.08
$7.19

Technical Indicators

Market Signals
Indicator
PASW
JSPR
Relative Strength Index (RSI) 41.59 39.02
Support Level $0.13 $0.62
Resistance Level $0.17 $1.03
Average True Range (ATR) 0.01 0.07
MACD -0.00 -0.01
Stochastic Oscillator 35.60 18.09

Price Performance

Historical Comparison
PASW
JSPR

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: